A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
Nadine Arnold(University of Sheffield), Allan Lawrie(University of Sheffield)
Cited by 34
Related Papers
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
|Circulation|2016|214
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension
|Journal of Clinical Investigation|2016|148
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
|Circulation|2017|144
Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
|The Journal of Experimental Medicine|2012|94
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
|American Journal of Respiratory and Critical Care Medicine|2020|73